Physician

Glenn A Mcdonald, MD

According to 2025 Medicare claims, Glenn Mcdonald, MD (NPI: 1336104389) practices nephrology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is EAST TEXAS KIDNEY SPECIALISTS,PA (NPI: 1184689622; TIN: 752896100) and primary practice location at 75605-0037. Mcdonald is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Mcdonald's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 805 traditional Medicare patients, billed 3,137 HCPCS/CPT codes, and received $264,220 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,899 prescription claims across 482 beneficiaries totaling $326,254 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 55 claims. Open Payments data shows 8 records totaling $174. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $396,847 to $264,220. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,188,884 to $326,254. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	876	3,998	$396,847
2016	903	4,263	$485,832
2017	891	4,024	$457,636
2018	853	3,700	$420,377
2019	956	3,189	$362,096
2020	1,042	4,017	$452,087
2021	897	3,067	$381,354
2022	826	2,636	$297,292
2023	748	2,615	$306,880
2024	805	3,137	$264,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	417	3,946	$1,188,884
2016	474	4,712	$954,232
2017	492	4,432	$765,079
2018	511	4,395	$485,312
2019	562	4,233	$328,328
2020	556	4,100	$328,677
2021	490	3,348	$235,387
2022	418	2,761	$180,992
2023	455	3,032	$247,345
2024	482	2,899	$326,254

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	130	$17,520
2016	N/R	232	$30,469
2017	N/R	201	$23,697
2018	N/R	136	$16,243
2019	N/R	117	$17,195
2020	N/R	84	$12,274
2021	N/R	76	$9,020
2022	N/R	49	$3,420
2023	N/R	59	$2,416
2024	N/R	55	$1,602

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	101	215	$275
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	95	95	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	434	834	$63
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	195	653	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	390	664	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	18	540	$67,614
Farxiga	Dapagliflozin Propanediol	98	3,690	$65,907
Jardiance	Empagliflozin	65	2,860	$56,308
Sevelamer Carbonate	Sevelamer Carbonate	127	5,480	$36,595
Eliquis	Apixaban	12	600	$11,314

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	15	$1,085
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$213
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$207
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	12	$97

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$174	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Glenn A. Mcdonald, MD?

Tedicare shows public-source Medicare data for Glenn A. Mcdonald, MD (NPI 1336104389), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Glenn A. Mcdonald, MD have ACO affiliation data?

Glenn A. Mcdonald, MD is shown with ACO affiliation data for CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Glenn A. Mcdonald, MD?

Glenn A. Mcdonald, MD is linked to EAST TEXAS KIDNEY SPECIALISTS,PA (billing NPI 1184689622) in the available physician profile data.

Does Glenn A. Mcdonald, MD have Open Payments data?

Glenn A. Mcdonald, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.